Vascular neoplasms with epithelioid cytomorphology encompass a wide spectrum of benign and malignant lesions, including epithelioid hemangioma (EH), cutaneous epithelioid angiomatous nodule (CEAN), epithelioid hemangioendothelioma (EHE), and epithelioid angiosarcoma (EAS). Recently, the first case of a cutaneous hemangioma with epithelioid features harboring a TPM3::ALK fusion was reported. Herein, we report 4 additional cases, including 1 case with an alternate TPM4::ALK fusion, and expand on the clinicopathologic and molecular genetic features of these unusual vascular lesions. Including the previously reported case, 5 tumors occurred in 4 male and 1 female patients with a median age of 14 years (range: 2 to 38 y) and involved the shoulder region (2), the lower extremity (1), trunk (1), and head and neck (1). Clinical follow-up (3 patients; 60%) showed no evidence of disease at the last follow-up (median: 5 mo; range: 1 to 16 mo). Histologically, all tumors showed highly similar morphologic features, including an epidermal collarette, well-formed vascular channels composed of epithelioid endothelial cells with intracytoplasmic vacuoles, and admixed inflammatory cells. Immunohistochemically, all tumors were positive for vascular markers such as ERG and CD31, along with strong and diffuse cytoplasmic expression of ALK. RNA sequencing revealed recurrent TPM3 exon 8 :: ALK exon 20 (4) and TPM4 exon 7 :: ALK exon 20 fusions (1). We conclude that cutaneous hemangiomas with epithelioid features harboring TPM3/4::ALK fusions show consistent morphologic, immunophenotypic, and molecular genetic features. It remains to be determined whether this neoplasm represents a distinct entity or a molecular variant of epithelioid hemangioma.

Biopticka Laboratory Pilsen Czech Republic

Department of Dermatopathology St John's Institute of Dermatology St Thomas' Hospital London UK

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN

Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center New York NY

Department of Pathology Brigham and Women's Hospital Harvard Medical School MA

Department of Pathology Institut Jules Bordet Brussels Belgium

Department of Pathology New York University

Department of Pathology University of Michigan Ann Arbor MI

Dermatologie Noerdlingen Germany

MVZ Dermatopathologie Friedrichshafen Bodensee PartG

Zobrazit více v PubMed

Board WCoTE. Soft tissue and bone tumours. vol 5th ed. IARC Press; 2020.

Tsuda Y, Suurmeijer AJH, Sung YS, Zhang L, Healey JH, Antonescu CR. Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study. Genes Chromosomes Cancer. Jan 2021;60(1):17–25. doi: 10.1002/gcc.22898 PubMed DOI PMC

Huang SC, Zhang L, Sung YS, et al. Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal. Am J Surg Pathol. Oct 2015;39(10):1313–21. doi: 10.1097/PAS.0000000000000469 PubMed DOI PMC

Dermawan JK, Westra WH, Antonescu CR. Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes. Genes Chromosomes Cancer. Apr 2022;61(4):187–193. doi: 10.1002/gcc.23017 PubMed DOI PMC

Linos K, Dermawan JK, Pulitzer M, et al. Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions. Genes Chromosomes Cancer. Jan 2024;63(1):e23198. doi: 10.1002/gcc.23198 PubMed DOI PMC

Nayler SJ, Rubin BP, Calonje E, Chan JK, Fletcher CD. Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. Am J Surg Pathol. Mar 2000;24(3):352–61. doi: 10.1097/00000478-200003000-00003 PubMed DOI

Walther C, Tayebwa J, Lilljebjorn H, et al. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol. Apr 2014;232(5):534–40. doi: 10.1002/path.4322 PubMed DOI

Bridge JA, Sumegi J, Royce T, Baker M, Linos K. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. Genes Chromosomes Cancer. Jan 2021;60(1):38–42. doi: 10.1002/gcc.22891 PubMed DOI

Agaram NP, Zhang L, Cotzia P, Antonescu CR. Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions. Am J Surg Pathol. Dec 2018;42(12):1653–1661. doi: 10.1097/PAS.0000000000001147 PubMed DOI PMC

Errani C, Zhang L, Sung YS, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. Aug 2011;50(8):644–53. doi: 10.1002/gcc.20886 PubMed DOI PMC

Mendlick MR, Nelson M, Pickering D, et al. Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol. May 2001;25(5):684–7. doi: 10.1097/00000478-200105000-00019 PubMed DOI

Antonescu CR, Le Loarer F, Mosquera JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. Aug 2013;52(8):775–84. doi: 10.1002/gcc.22073 PubMed DOI PMC

Dermawan JK, Azzato EM, Billings SD, et al. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases. Mod Pathol. Dec 2021;34(12):2211–2221. doi: 10.1038/s41379-021-00879-7 PubMed DOI

Linos K, Chang JC, Busam KJ. A cutaneous epithelioid vascular tumor harboring a TPM3::ALK fusion. Genes Chromosomes Cancer. Jan 2024;63(1):e23207. doi: 10.1002/gcc.23207 PubMed DOI PMC

Zhu G, Benayed R, Ho C, et al. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Mod Pathol. May 2019;32(5):609–620. doi: 10.1038/s41379-018-0175-7 PubMed DOI PMC

Torrence D, Dermawan JK, Zhang Y, et al. Detection of GRM1 gene rearrangements in chondromyxoid fibroma: a comparison of fluorescence in-situ hybridisation, RNA sequencing and immunohistochemical analysis. Histopathology. Jun 18 2024;doi: 10.1111/his.15248 PubMed DOI

Meng Y, Huang K, Shi M, et al. Research Advances in the Role of the Tropomyosin Family in Cancer. Int J Mol Sci. Aug 27 2023;24(17)doi: 10.3390/ijms241713295 PubMed DOI PMC

Holla VR, Elamin YY, Bailey AM, et al. ALK: a tyrosine kinase target for cancer therapy. Cold Spring Harb Mol Case Stud. Jan 2017;3(1):a001115. doi: 10.1101/mcs.a001115 PubMed DOI PMC

Shreenivas A, Janku F, Gouda MA, et al. ALK fusions in the pan-cancer setting: another tumor-agnostic target? NPJ Precis Oncol. Sep 29 2023;7(1):101. doi: 10.1038/s41698-023-00449-x PubMed DOI PMC

Drieux F, Ruminy P, Sater V, et al. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay. J Mol Diagn. Aug 2021;23(8):929–940. doi: 10.1016/j.jmoldx.2021.04.013 PubMed DOI

Siebert R, Gesk S, Harder L, et al. Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large-cell lymphoma. Blood. Nov 15 1999;94(10):3614–7. PubMed

Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood. May 1 1999;93(9):3088–95. PubMed

Reading NS, Jenson SD, Smith JK, Lim MS, Elenitoba-Johnson KS. 5’-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma. J Mol Diagn. May 2003;5(2):136–40. doi: 10.1016/S1525-1578(10)60463-1 PubMed DOI PMC

Cajaiba MM, Jennings LJ, Rohan SM, et al. ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer. May 2016;55(5):442–51. doi: 10.1002/gcc.22346 PubMed DOI

Cajaiba MM, Jennings LJ, George D, Perlman EJ. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript. Genes Chromosomes Cancer. Oct 2016;55(10):814–7. doi: 10.1002/gcc.22382 PubMed DOI PMC

Sukov WR, Hodge JC, Lohse CM, et al. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol. Nov 2012;25(11):1516–25. doi: 10.1038/modpathol.2012.107 PubMed DOI

Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5:3116. doi: 10.1038/ncomms4116 PubMed DOI PMC

Wu G, Barnhill RL, Lee S, et al. The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing. Mod Pathol. Apr 2016;29(4):359–69. doi: 10.1038/modpathol.2016.37 PubMed DOI PMC

Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. Aug 2000;157(2):377–84. doi: 10.1016/S0002-9440(10)64550-6 PubMed DOI PMC

Lovly CM, Gupta A, Lipson D, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. Aug 2014;4(8):889–95. doi: 10.1158/2159-8290.CD-14-0377 PubMed DOI PMC

Kerr DA, Thompson LDR, Tafe LJ, et al. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Am J Surg Pathol. Dec 1 2021;45(12):1707–1719. doi: 10.1097/PAS.0000000000001735 PubMed DOI

Yamamoto H, Yoshida A, Taguchi K, et al. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology. Jul 2016;69(1):72–83. doi: 10.1111/his.12910 PubMed DOI

Kazakov DV, Kyrpychova L, Martinek P, et al. ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings. Am J Dermatopathol. Nov 2018;40(11):805–814. doi: 10.1097/DAD.0000000000001085 PubMed DOI

Luedersen J, Stadt UZ, Richter J, et al. Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group. Br J Haematol. May 2024;204(5):1894–1898. doi: 10.1111/bjh.19308 PubMed DOI

Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion. Blood. Aug 15 2001;98(4):1209–16. doi: 10.1182/blood.v98.4.1209 PubMed DOI

Lee JC, Li CF, Huang HY, et al. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. J Pathol. Feb 2017;241(3):316–323. doi: 10.1002/path.4836 PubMed DOI PMC

Goerdt LV, Schneider SW, Booken N. Cutaneous Angiosarcomas: Molecular Pathogenesis Guides Novel Therapeutic Approaches. J Dtsch Dermatol Ges. Apr 2022;20(4):429–443. doi: 10.1111/ddg.14694 PubMed DOI

Espejo-Freire AP, Elliott A, Rosenberg A, et al. Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis. Cancers (Basel). Sep 26 2021;13(19)doi: 10.3390/cancers13194816 PubMed DOI PMC

Doyle LA, Fletcher CD, Hornick JL. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics. Am J Surg Pathol. Jan 2016;40(1):94–102. doi: 10.1097/PAS.0000000000000511 PubMed DOI

Li S, Dermawan JK, Seavey CN, Ma S, Antonescu CR, Rubin BP. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant. Genes Chromosomes Cancer. Feb 2024;63(2):e23226. doi: 10.1002/gcc.23226 PubMed DOI PMC

Brenn T, Fletcher CD. Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors. Am J Dermatopathol. Feb 2004;26(1):14–21. doi: 10.1097/00000372-200402000-00003 PubMed DOI

Goto K, Ogawa K, Fukai T, et al. Categorization of cutaneous epithelioid angiomatous nodule as epithelioid hemangioma or angiolymphoid hyperplasia with eosinophilia: Clinicopathologic, immunohistochemical, and molecular analyses of seven lesions. J Cutan Pathol. Sep 2022;49(9):765–771. doi: 10.1111/cup.14246 PubMed DOI

Hung YP, Fletcher CD, Hornick JL. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma. Am J Surg Pathol. May 2017;41(5):596–606. doi: 10.1097/PAS.0000000000000795 PubMed DOI

Papke DJ Jr., Hornick JL. What is new in endothelial neoplasia? Virchows Arch. Jan 2020;476(1):17–28. doi: 10.1007/s00428-019-02651-4 PubMed DOI

Luzar B, Ieremia E, Antonescu CR, Zhang L, Calonje E. Cutaneous intravascular epithelioid hemangioma. A clinicopathological and molecular study of 21 cases. Mod Pathol. Aug 2020;33(8):1527–1536. doi: 10.1038/s41379-020-0505-4 PubMed DOI PMC

Tepp JA, Agaram NP, Chang JC, Linos K. Cellular Cutaneous Epithelioid Hemangioma Harboring the Rare GATA6::FOXO1 Gene Fusion. Am J Dermatopathol. Apr 1 2024;46(4):223–227. doi: 10.1097/DAD.0000000000002647 PubMed DOI PMC

Antonescu CR, Huang SC, Sung YS, et al. Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma. Mod Pathol. May 2021;34(5):934–941. doi: 10.1038/s41379-020-00723-4 PubMed DOI PMC

Antonescu CR, Chen HW, Zhang L, et al. ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features. Genes Chromosomes Cancer. Nov 2014;53(11):951–9. doi: 10.1002/gcc.22206 PubMed DOI PMC

Doyle LA, Marino-Enriquez A, Fletcher CD, Hornick JL. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol. Jul 2015;28(7):904–12. doi: 10.1038/modpathol.2015.49 PubMed DOI